Literature DB >> 25798424

Characteristics of hereditary nonpolyposis colorectal cancer patients with double primary cancers in endometrium and colorectum.

So Hyun Shin1, Eun Jeong Yu1, Yoo-Kyung Lee1, Yong-Sang Song1, Moon-Woo Seong2, Sung Sup Park2.   

Abstract

OBJECTIVE: The hereditary nonpolyposis colorectal cancer is inherited syndrome characterized by the development of cancers in various organ system; these includes colorectum, endometrium, and less frequently, small bowel, stomach, urinary tract, ovaries, and brain. We aimed to investigate the clinicopathologic characteristics of hereditary nonpolyposis colorectal cancer patients who had both endometrial and colorectal cancers.
METHODS: Between January 2004 and December 2013, 12 women diagnosed with endometrial and colorectal cancers in a single institution were included in this analysis. For these patients, clinical and molecular findings were analyzed retrospectively.
RESULTS: All 12 women undertook microsatellite instability analysis, and 9 (75%) were confirmed of having microsatellite instability-high. Among 9 cases with immunohistochemical staining for MLH1 and MSH2, 6 were positive for the loss of mismatch repair protein. Mutational analyses for MLH1 and MSH2 were performed in 3 out of 12 patients; all of them showed germline mutation.
CONCLUSION: This study suggests that there is a genetic background in patients with double primary malignancies in their endometrium and colorectum when analyzed with microsatellite instability studies, immunohistochemistry staining, and mutation studies. This finding supports the necessity of re-defining the high-risk groups in endometrial cancers clinically. This will also help diagnose malignancies in such patients in early stages, as well as counsel other family members.

Entities:  

Keywords:  Colorectal neoplasms, hereditary nonpolyposis; Endometrial neoplasms; MLH1; MSH2

Year:  2015        PMID: 25798424      PMCID: PMC4366863          DOI: 10.5468/ogs.2015.58.2.112

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  14 in total

Review 1.  The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.

Authors:  C Richard Boland; Minoru Koi; Dong K Chang; John M Carethers
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

2.  Tissue preparation for histochemistry: fixation, embedding, and antigen retrieval for light microscopy.

Authors:  Tim D Hewitson; Belinda Wigg; Gavin J Becker
Journal:  Methods Mol Biol       Date:  2010

3.  Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.

Authors:  Ki-Hyuk Shin; Joo-Ho Shin; Jung-Hwa Kim; Jae-Gahb Park
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

4.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Hereditary non-polyposis colorectal cancer/Lynch syndrome in Korean patients with endometrial cancer.

Authors:  Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Moon-Woo Seong; Bo-Yon Lee; Sang-Yoon Park
Journal:  Jpn J Clin Oncol       Date:  2010-10-21       Impact factor: 3.019

6.  Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study.

Authors:  Jae-Gahb Park; Hans F A Vasen; Young Jin Park; Kyu Joo Park; Paivi Peltomaki; Maurizio Ponzo de Leon; Miguel A Rodriguez-Bigas; Jan Lubinski; Nicholas E Beck; Marie-Luise Bisgaard; Michiko Miyaki; Juul T Wijnen; Shozo Baba; Annika Lindblom; Lisa Madlensky; Henry T Lynch
Journal:  Int J Colorectal Dis       Date:  2002-03       Impact factor: 2.571

7.  Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).

Authors:  A Loukola; K Eklin; P Laiho; R Salovaara; P Kristo; H Järvinen; J P Mecklin; V Launonen; L A Aaltonen
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

8.  Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry.

Authors:  Shan-Rong Shi; Cheng Liu; Llana Pootrakul; Laurie Tang; Andrew Young; Ryan Chen; Richard J Cote; Clive R Taylor
Journal:  Am J Clin Pathol       Date:  2008-03       Impact factor: 2.493

9.  Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.

Authors:  Karen H Lu; John O Schorge; Kerry J Rodabaugh; Molly S Daniels; Charlotte C Sun; Pamela T Soliman; Kristin G White; Rajyalakshmi Luthra; David M Gershenson; Russell R Broaddus
Journal:  J Clin Oncol       Date:  2007-10-09       Impact factor: 44.544

Review 10.  Association of HNPCC and endometrial cancers.

Authors:  Kouji Banno; Nobuyuki Susumu; Megumi Yanokura; Takeshi Hirao; Takashi Iwata; Akira Hirasawa; Daisuke Aoki; Kokichi Sugano; Shiro Nozawa
Journal:  Int J Clin Oncol       Date:  2004-08       Impact factor: 3.402

View more
  3 in total

1.  Case Report of Menopausal Woman Diagnosed with Endometrial Cancer after Colon Cancer with Germline Mutation in MSH6 in Korea.

Authors:  Hyun Jung Lee; Min Hee Lee; Min Chul Choi; Sang Geun Jung; Won Duk Joo; Tae Hoen Kim; Chan Lee; Ja-Hyun Jang
Journal:  J Menopausal Med       Date:  2017-04-28

2.  Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test.

Authors:  Yoo-Na Kim; Min Kyu Kim; Young Joo Lee; Youngeun Lee; Ji Yeon Sohn; Jung-Yun Lee; Min Chul Choi; Migang Kim; Sang Geun Jung; Won Duk Joo; Chan Lee
Journal:  Cancers (Basel)       Date:  2022-07-13       Impact factor: 6.575

3.  Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.

Authors:  Chris Stinton; Mary Jordan; Hannah Fraser; Peter Auguste; Rachel Court; Lena Al-Khudairy; Jason Madan; Dimitris Grammatopoulos; Sian Taylor-Phillips
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.